Skip to main content
Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
8.48
+0.17 (2.05%)
Dec 20, 2024, 4:00 PM EST - Market closed

Inogen Revenue

Inogen had revenue of $88.83M in the quarter ending September 30, 2024, with 5.80% growth. This brings the company's revenue in the last twelve months to $331.52M, up 1.12% year-over-year. In the year 2023, Inogen had annual revenue of $315.66M, down -16.32%.

Revenue (ttm)
$331.52M
Revenue Growth
+1.12%
P/S Ratio
0.60
Revenue / Employee
$397,506
Employees
834
Market Cap
201.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023315.66M-61.58M-16.32%
Dec 31, 2022377.24M19.24M5.37%
Dec 31, 2021358.00M49.52M16.05%
Dec 31, 2020308.49M-53.46M-14.77%
Dec 31, 2019361.94M3.83M1.07%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 141.33M
Biodesix 65.56M
Inventiva 20.65M
Verastem 10.00M
Akso Health Group 2.41M
Inhibrx Biosciences 1.57M
Perspective Therapeutics 1.56M
Atai Life Sciences 331.00K
Revenue Rankings

INGN News

More News